Cellular Adoptive Immunotherapy in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma

NCT00182650 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: aldesleukin
BIOLOGICAL: rituximab
BIOLOGICAL: therapeutic autologous lymphocytes
DRUG: fludarabine phosphate

Sponsor

City of Hope Medical Center

Collaborators

[object Object]